Topline Flash Note: Citi Pharma Ltd (CPHL): Corporate Briefing Key Takeaways
Citi Pharma Ltd (CPHL) conducted its analyst briefing session today to discuss business performance and outlook. Company's biotech insulin...
198 Views
Citi Pharma (CPHL): 4QFY25 EPS At Rs0.94, FY25 EPS At Rs3.90 (Earnings In Line With Expectations)
Citi Pharma (CPHL) announced its 4QFY25 result today, where the company recorded earnings of Rs214mn (EPS of Rs0.94), up 41% YoY while down by 3%...
236 Views
Pakistan Pharmaceuticals: Pharma Sector Analysis FY24; Deregulation Improved Sales and Margins
Pakistan listed pharmaceuticals sector's earnings were up 70% YoY to Rs13.3bn in fiscal year 2024. This jump in profitability is...
810 Views
Citi Pharma (CPHL): 1QFY25 EPS at Rs0.88 up 32% QoQ (Earnings higher than expectations)
Citi Pharma (CPHL) announced its 1QFY25 result today, where the company recorded earnings of Rs201mn (EPS of Rs0.88), up 114% YoY and 32%...
412 Views
Pakistan Equity - Citi Pharma (CPHL) Joint Venture with Hangzhou Newsea Technology Co Limited
In a notice on the exchange, CPHL announced Joint Venture (JV) with Hangzhou Newsea Technology Co Limited, a renowned player in pharmaceutical...
362 Views